In the two-month intervention of Patti et al. (2020) involving 23 patients with MetS and moderate hepatic steatosis, daily consumption of 32 g of HP-EVOO resulted in lower liver fat content (p = 0.043), improved liver enzyme levels (ALT and AST, p < 0.05) and better liver stiffness score (p = 0.037) compared to baseline [51]. The gene discussed is GPT; the disease is fatty liver disease.